Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''

Samantha Bowyer; Prashanth Prithviraj; Paul Lorigan; James Larkin; Grant McArthur; Victoria Atkinson; Michael Millward; Muoi Khou; Stefan Diem; Sangeetha Ramanujam; Ben Kong; Elizabeth Liniker; Alexander Guminski; Phillip Parente; Miles C. Andrews; Sagun Parakh; Jonathan Cebon; Georgina V. Long; Matteo S. Carlino; Oliver Klein

doi:10.1038/bjc.2017.59

Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''

Samantha Bowyer, Prashanth Prithviraj, Paul Lorigan, James Larkin, Grant McArthur, Victoria Atkinson, Michael Millward, Muoi Khou, Stefan Diem, Sangeetha Ramanujam, Ben Kong, Elizabeth Liniker, Alexander Guminski, Phillip Parente, Miles C. Andrews, Sagun Parakh, Jonathan Cebon, Georgina V. Long, Matteo S. Carlino, Oliver Klein

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	e15
Journal	British Journal of Cancer
Volume	116
Issue number	8
DOIs	https://doi.org/10.1038/bjc.2017.59
Publication status	Published - 11 Apr 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/bjc.2017.59Licence: CC BY-NC-SA

Cite this

Bowyer, S., Prithviraj, P., Lorigan, P., Larkin, J., McArthur, G., Atkinson, V., Millward, M., Khou, M., Diem, S., Ramanujam, S., Kong, B., Liniker, E., Guminski, A., Parente, P., Andrews, M. C., Parakh, S., Cebon, J., Long, G. V., Carlino, M. S., & Klein, O. (2017). Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''. British Journal of Cancer, 116(8), e15. https://doi.org/10.1038/bjc.2017.59

@article{f81bf2c12da14025bd5c58cc0bf45c28,

title = "Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''",

author = "Samantha Bowyer and Prashanth Prithviraj and Paul Lorigan and James Larkin and Grant McArthur and Victoria Atkinson and Michael Millward and Muoi Khou and Stefan Diem and Sangeetha Ramanujam and Ben Kong and Elizabeth Liniker and Alexander Guminski and Phillip Parente and Andrews, {Miles C.} and Sagun Parakh and Jonathan Cebon and Long, {Georgina V.} and Carlino, {Matteo S.} and Oliver Klein",

year = "2017",

month = apr,

day = "11",

doi = "10.1038/bjc.2017.59",

language = "English",

volume = "116",

pages = "e15",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "8",

}

Bowyer, S, Prithviraj, P, Lorigan, P, Larkin, J, McArthur, G, Atkinson, V, Millward, M, Khou, M, Diem, S, Ramanujam, S, Kong, B, Liniker, E, Guminski, A, Parente, P, Andrews, MC, Parakh, S, Cebon, J, Long, GV, Carlino, MS & Klein, O 2017, 'Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''', British Journal of Cancer, vol. 116, no. 8, pp. e15. https://doi.org/10.1038/bjc.2017.59

TY - JOUR

T1 - Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''

AU - Bowyer, Samantha

AU - Prithviraj, Prashanth

AU - Lorigan, Paul

AU - Larkin, James

AU - McArthur, Grant

AU - Atkinson, Victoria

AU - Millward, Michael

AU - Khou, Muoi

AU - Diem, Stefan

AU - Ramanujam, Sangeetha

AU - Kong, Ben

AU - Liniker, Elizabeth

AU - Guminski, Alexander

AU - Parente, Phillip

AU - Andrews, Miles C.

AU - Parakh, Sagun

AU - Cebon, Jonathan

AU - Long, Georgina V.

AU - Carlino, Matteo S.

AU - Klein, Oliver

PY - 2017/4/11

Y1 - 2017/4/11

UR - http://www.scopus.com/inward/record.url?scp=85015808940&partnerID=8YFLogxK

U2 - 10.1038/bjc.2017.59

DO - 10.1038/bjc.2017.59

M3 - Letter

C2 - 28324885

AN - SCOPUS:85015808940

SN - 0007-0920

VL - 116

SP - e15

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 8

ER -

Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''

UN SDGs

Access to Document

Other files and links

Cite this